期刊文献+

Changes of NF-κB activity in colon carcinoma cells treated with different crude extracts of abrotani herba

青蒿不同溶剂萃取粗提物对结肠癌HT-29、Lovo细胞NF-κB活性的影响(英文)
下载PDF
导出
摘要 Objective: To study changes of NF-κB activity in colon carcinoma cell lines treated with different crude extracts of abrotani herba obtained through solvent extraction methods. Methods: Crude extracts of abrotani herba were extracted with ligarine, chloroform, acetoacetate and n-butanol in separating funnel. Exposure concentration of crude extracts were obtained through detecting viability of HT-29 cells by MTT. Then HT-29 cells and Lovo cells were treated with different crude extracts respectively. Changes of NF-κB activity in HT-29 cells and Lovo cells using different crude extracts were observed by EMSA. Results: Successfully extracted different crude extracts of abrotani herba and called them ligarine extract, chloroform extract, acetoacetate extract, n-butanol extract and remaining extract for short. NF-κB activity was significantly inhibited in HT-29 cells treated with chloroform extract, there were no significant differences in other groups compared with the control. The same change of NF-κB activity was observed in Lovo cells using different crude extracts of abrotani herba. Conclusion: NF-κB activity can be inhibited in colon carcinoma HT-29 cells and Lovo cells treated with chloroform extract obtained from abrotani herba through the method of solvent extraction.
机构地区 Department of Oncology
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2008年第8期465-468,共4页 中德临床肿瘤学杂志(英文版)
基金 a grant from the Project of Tackling Key Problems in Science and Technology Foundation of Chongqing (No. 9398)
关键词 abrotani herba solvent extraction colon carcinoma NF-ΚB 青蒿不同溶剂萃取粗提物 结肠癌HT一29 Lovo细胞 NF—K B活性
  • 相关文献

参考文献11

  • 1Fong WF, Wang C, Zhu GY, et al. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract. Phytomedicine, 2007, 14: 160-165. 被引量:1
  • 2Marcsek ZL, Kocsis Z, Szende B. Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells. Cell Biol Int, 2007, 31: 1214-1219. 被引量:1
  • 3Lai H, Singh NP. Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett, 2006, 231: 43-48. 被引量:1
  • 4Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcnption factor NF-kappaB. J Clin Invest, 2001, 107: 241-246. 被引量:1
  • 5Janssens S, Tinel A, Lippens S, et al. PIDD mediates NF-kappaB activation in response to DNA damage. Cell, 2005, 123:1079-1092. 被引量:1
  • 6Luo JL, Kamata H, Kann M. IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest, 2005, 115: 2625-2632. 被引量:1
  • 7Frelin C, Imbert V, Griessinger E, et al. Targeting NF-kappaB activiation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells. Blood, 2005, 105: 804-811. 被引量:1
  • 8Kann M, Cao Y, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culpnt. Nat Rev Cancer, 2002, 2: 301-310. 被引量:1
  • 9Singh NP, Lai HC. Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res, 2005, 25: 4325- 4331. 被引量:1
  • 10Disbrow GL, BaegeAC, Kierpiec KA, et al. Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res, 2005, 65: 10854-10861. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部